UBC9 in bladder cancer cells is required to maintain high sumoylation levels and alleviate stress-related inflammation threats to cell survival, while lack of UBC9 contributes to stem cell-like population formation and cancer progression by activated inflammation. This evidence concerns the gene UBE2I and urinary bladder carcinoma.